HiberGene

HiberGene Diagnostics Limited is a private Irish company operating in the $57 billion in-vitro diagnostics market. Its Chairman and CEO is Brendan K Farrell, a veteran of the diagnostics industry. The company is focussed on applying molecular technology to the infectious disease segment of the diagnostic market.

© HiberGene 2014